Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Enzyme-linked immunosorbent assay (ELISA) indicates a plate-based antibody assay method. It is practiced to identify and estimate the concentration of antigen, proteins, peptides, antibodies, or hormone in a sample. In this technique, the antigen or the testing element is made immobile or fixed on a solid surface, and it is further reacted with a specific antibody linked to an enzyme. The growth of color confirms the presence of antigen, or the contrasting color textures provide insights about the varying antigen concentrations.

MARKET DYNAMICS

The enzyme-linked immunosorbent assay (ELISA) market is driving due to the rise in the number of chronic diseases, growing demand for the enzyme-linked immunosorbent assay (ELISA) tests. However, the lack of accessibility and affordability of diagnostic tests in developing countries hinders the market's growth. Moreover, the growing need for frequent diagnostic testing among the aging population is expected to provide opportunities in the global enzyme-linked immunosorbent assay (ELISA) market.

MARKET SCOPE

The "Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of enzyme-linked immunosorbent assay (ELISA) market with detailed market segmentation by solution, application, and end user. The enzyme-linked immunosorbent assay (ELISA) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in enzyme-linked immunosorbent assay (ELISA) market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The enzyme-linked immunosorbent assay (ELISA) market is segmented on the basis of type, application, and end user. Based on type, the market is segmented sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on application, the market is segmented as cancer, HIV AIDS, inflammation disorders, protein quantification, and others. Based on end user, the market is segmented as hospitals & diagnostics centers, research laboratories, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Enzyme-linked immunosorbent assay (ELISA) market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The enzyme-linked immunosorbent assay (ELISA) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting enzyme-linked immunosorbent assay (ELISA) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Enzyme-linked immunosorbent assay (ELISA) market in these regions.

MARKET PLAYERS

The report covers key developments in the enzyme-linked immunosorbent assay (ELISA) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Enzyme-linked immunosorbent assay (ELISA) market are anticipated to have lucrative growth opportunities in the future with the rising demand for Enzyme-linked immunosorbent assay (ELISA) in the global market. Below mentioned is the list of few companies engaged in the Enzyme-linked immunosorbent assay (ELISA) market.

The report also includes the profiles of key players in enzyme-linked immunosorbent assay (ELISA) market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   American Laboratory Products Company (ALPCO)
  
•   BD
  
•   BioLegend, Inc.
  
•   Bio-Rad Laboratories, Inc.
  
•   Abbott Laboratories
  
•   Abcam Plc
  
•   bioMerieux SA
  
•   Enzo Life Sciences, Inc.
  
•   Thermo Fisher Scientific Inc.
  
•   Merck KGaA
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Enzyme-Linked Immunosorbent Assay (ELISA) Report Scope